Researcher
Barbara De Moerloose
- Keywords:acute myeloid leukemia, juvenile myelomonocytic leukemia, CART treatment, bone marrow failure, myelodysplasia, acute lymfoblastic leukemia
- Disciplines:Paediatrics and neonatology, Cancer therapy, Hematology, Cancer biology, Cancer diagnosis
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Pediatrics and medical genetics (Department)
Member
From1 Oct 1994 → 30 Sep 2018
Projects
1 - 5 of 5
- Research assignment of Prof. dr. Tim Lammens, framing the ongoing clinical-translational research at the Department of Pediatric Hematology-Oncology and Stem Cell TransplantationFrom1 Oct 2023 → TodayFunding: Nonprofit institution or equivalents
- Integration of genome, epigenome, and transcriptome in juvenile myelomonocytic leukemia and functional analysis of circular RNAs as novel biomarker and/or therapeutic targetsFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Preclinical evaluation of newly identified therapeutic targets in pediatric acute myeloid leukemiaFrom1 Oct 2021 → TodayFunding: Nonprofit institution or equivalents
- Long non-coding RNAs as therapeutic targets in acute myeloid leukemiaFrom1 Oct 2020 → 30 Sep 2021Funding: Nonprofit institution or equivalents
- Evaluation of the prognostic value of the leukemic stem cell (LSC) and pre-leukemic hematopoietic stem cell (pre-L HSC) for minimal residual disease monitoring and clinical management of pediatric acute myeloid leukemia patientsFrom1 Jan 2015 → 31 Dec 2018Funding: Foundations, funds and other with scientific goal
Publications
31 - 40 of 137
- Clinical significance of TARP expression in pediatric acute myeloid leukemia(2020)
Authors: Barbara Depreter, Barbara De Moerloose, Karl Vandepoele, Anne Uyttebroeck, An Van Damme, Barbara Denys, Laurence Dedeken, Marie-Françoise Dresse, Jutte Van Der Werff Ten Bosch, Mattias Hofmans, et al.
- Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia(2019)
Authors: Ditte JA Lohmann, Peter H Asdahl, Jonas Abrahamsson, Shau-Yin Ha, Olafur G Jonsson, Gertjan JL Kaspers, Minna Koskenvuo, Birgitte Lausen, Barbara De Moerloose, Josefine Palle, et al.
Pages: 6634 - 6643 - Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia : a global, single-arm, phase 2 trial(2019)
Authors: Theodore W. Laetsch, Gary Douglas Myers, Andre Baruchel, Andrew C. Dietz, Michael A. Pulsipher, Henrique Bittencourt, Jochen Buechner, Barbara De Moerloose, Kara L. Davis, Eneida Nemecek, et al.
Pages: 1710 - 1718 - The strategic plan for paediatric cancer treatment in Belgium(2019)
Authors: A Van Damme, Barbara De Moerloose, B Brichard, A Ferster, B Heenen, Genevieve Laureys, Koen Norga, C Piette, Jutte Van Der Werff Ten Bosch, Anne Uyttebroeck
Pages: 21 - 26 - Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors(2019)
Authors: François Doz, Franco Locatelli, André Baruchel, Nicolas Blin, Barbara De Moerloose, Didier Frappaz, Michael Dworzak, Matthias Fischer, Jan Stary, Rene Fuertig, et al.
- Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01(2019)
Authors: Barbara De Moerloose, Ardine Reedijk, Geertruida H. de Bock, Tim Lammens, Valerie de Haas, Barbara Denys, Laurence Dedeken, Marry M. van den Heuvel-Eibrink, Maroeska te Loo, Anne Uyttebroeck, et al.
- Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01(2019)
Authors: Ditte JA Lohmann, Peter H Asdahl, Jonas Abrahamsson, Shau-Yin Ha, Olafur G Jonsson, Gertjan JL Kaspers, Minna Koskenvuo, Birgitte Lausen, Barbara De Moerloose, Josefine Palle, et al.
- Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma(2018)
Authors: Renate De Smedt, Sofie Peirs, Julie Morscio, Filip Matthijssens, Juliette Roels, Lindy Reunes, Béatrice Lintermans, Steven Goossens, Tim Lammens, Nadine Van Roy, et al.
Pages: e17 - e20 - Retrospective study of infant leukaemia in the University Hospitals of Leuven and Ghent(2018)
Authors: Barbara De Moerloose, E Nauwynck, K Arts, Leen Willems, V Labarque, Tim Lammens, A Uyttebroeck
Pages: 57 - 63 - Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia(2018)
Authors: Ditte JA Løhmann, Peter H Asdahl, Jonas Abrahamsson, Shau-Yin Ha, Ólafur G Jónsson, Gertjan JL Kaspers, Minna Koskenvuo, Birgitte Lausen, Barbara De Moerloose, Josefine Palle, et al.